• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • Quality Assessment Rounds
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / Database

Database

GAiT is currently building a specialised database for clinical grade iPSCs. This will take several months to build, test, and get online. In the meantime, GAiT recommends that information about candidate lines be registered on the hPSCReg database (Seltmann et al., 2016). This database is developed for research-grade iPSC lines but many of the categories for information deposition are similar to that that will be required by the GAiT database.

Ethical approval information and scientific information can also be included in the hPSCReg database. The requirements that hPSCReg database makes depositors go through, ensure they collect all pertinent information and such registered lines are useful throughout most of Europe and are very similar to the format used by NIH in the USA.

The hPSCReg database contains information on over 1,000 human pluripotent stem cell lines, including the EIBSC catalogue of cells, and the design of the hPSCReg database allows transfer of information to the new GAiT database so most of the material will not require re-insertion when the new database is operational. Many countries look to hPSCReg for validation of cell lines. Grants are dependent on hPSCReg issues certificates. The European Commission sees the benefits of getting a hPSCReg certificate as they do not presently have to re-contact the originator / deriver of the lines and start from scratch to confirm ethical provenance.

Table showing Mandatory Donation, Procurement, and Testing Data Fields for clinical-grade iPSCs in GAiT’s haplobank system

Donation, Procurement & testing of celluarPermissiveness of donor consentConsent FormResearch use?
Genetic analysis?
Commercial use?
Attestation 
Donor selection criteriaImmunotypingBloodtype
HLA Type l
HLA Type ll
KIR
Regulatory complianceEstablishment type 
GMP statusCompliant?
Licence/Registration status2004/23/ECcompliant? (EU)
2002/98/EC compliant? (EU)
Part 1271 compliant?(US)
CTO Regulation? (Canada)
CSA compliant? (Canada)
Category 1 Outsourcing inst? (Japan)
Category 2 Outsourcing inst? (Japan)
Category 3 Outsourcing inst? (Japan)
AccreditionAABB?
AATB?
FACT?
Other?
Donor health assessment and donor testingGeneralSex
Age
Geographic Location
Year
Tissue Type
 Infectious diseaseScreening According to local requirement
Physcial Exam

While registering the lines is not a legal requirement in many countries like the USA, it was strongly encouraged by GAiT and others, as it assists the standardisation of nomenclature which can then be used thereafter.

Nomenclature length and format is important so all the information can be transcribed onto a single cryovial. Consequently, nomenclature development must be done systematically as one cannot depend on the line originators / derivers to adhere to any format that can be fit on a vial (Seltmann et al., 2016). Registering the line also allows unique nomenclature to be used, reducing the risk of confusion in the literature or research studies thereafter.

Inputing the information into hPSCReg database and gaining approval, allows the user to format information relating to cell provenance and characterisation which in itself will act as a useful data checklist and give depositors greater surety that their line will ultimately be accepted into the GAiT clinical-grade database.

The GAiT Clinical Grade iPSC search engine and database is currently being developed.

The database forms a vital part of the initial attrition process for source material suitability. By doing this prior to full line generation and registration into banking system, extensive waste and expense will be avoided.

To access the Database, users are asked to register with GAiT. [Link to username/password request]

References

ANDREWS, P. W., BAKER, D., BENVINISTY, N., MIRANDA, B., BRUCE, K., BRUSTLE, O., CHOI, M., CHOI, Y. M., CROOK, J. M., DE SOUSA, P. A., DVORAK, P., FREUND, C., FIRPO, M., FURUE, M. K., GOKHALE, P., HA, H. Y., HAN, E., HAUPT, S., HEALY, L., HEI, D. J., HOVATTA, O., HUNT, C., HWANG, S. M., INAMDAR, M. S., ISASI, R. M., JACONI, M., JEKERLE, V., KAMTHORN, P., KIBBEY, M. C., KNEZEVIC, I., KNOWLES, B. B., KOO, S. K., LAABI, Y., LEOPOLDO, L., LIU, P., LOMAX, G. P., LORING, J. F., LUDWIG, T. E., MONTGOMERY, K., MUMMERY, C., NAGY, A., NAKAMURA, Y., NAKATSUJI, N., OH, S., OH, S. K., OTONKOSKI, T., PERA, M., PESCHANSKI, M., PRANKE, P., RAJALA, K. M., RAO, M., RUTTACHUK, R., REUBINOFF, B., RICCO, L., ROOKE, H., SIPP, D., STACEY, G. N., SUEMORI, H., TAKAHASHI, T. A., TAKADA, K., TALIB, S., TANNENBAUM, S., YUAN, B. Z., ZENG, F. & ZHOU, Q. 2015. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med, 10, 1-44.

CARPENTER, M. K. & RAO, M. S. 2015. Concise review: making and using clinically compliant pluripotent stem cell lines. Stem Cells Transl Med, 4, 381-8.

SELTMANN, S., LEKSCHAS, F., MULLER, R., STACHELSCHEID, H., BITTNER, M. S., ZHANG, W., KIDANE, L., SERIOLA, A., VEIGA, A., STACEY, G. & KURTZ, A. 2016. hPSCreg–the human pluripotent stem cell registry. Nucleic Acids Res, 44, D757-63.


Access to the iPSC Database is for GAiT Members only. Please Login

If you would like to gain access to the iPSC database, please contact admin at: stephen.sullivan@gait.global

Primary Sidebar

Search Users

GAiT News

IPSCtherapies avatar; GAiT @IPSCtherapies ·
7h 1526965177769508864

Speaker line up for NYSCF's annual conference 18-19th October 2022 has been announced.

Image for twitter card

2022 NYSCF Conference

The NYSCF Conference is the premier translational stem cell research conference. Held annually for the past 16 years...

conference.nyscf.org

Reply on Twitter 1526965177769508864 Retweet on Twitter 1526965177769508864 0 Like on Twitter 1526965177769508864 1 Twitter 1526965177769508864
IPSCtherapies avatar; GAiT @IPSCtherapies ·
6 May 1522493868750553091

Members of GAiT's industrial liaison committee @FeyeuxMaxime and @AndyG_0 (representing @treefrogtx and @STEMCELLTech respectively) speak with GAiT Director & @CCRM CEO @MichaelMay5 at #ISCT2022

Image for the Tweet beginning: Members of GAiT's industrial liaison Twitter feed image.
Reply on Twitter 1522493868750553091 Retweet on Twitter 1522493868750553091 1 Like on Twitter 1522493868750553091 7 Twitter 1522493868750553091
IPSCtherapies avatar; GAiT @IPSCtherapies ·
5 May 1522258567692177409

Lots of discussion of what constitutes 'suitable donor material' for iPSC therapeutics at #ISCT2022. This is considered in a white paper that GAiT, ISCBI, CIRM, CT-TRACS and ISCT is developing based on the PSC Manufacturing Expert Panels held in LA.

Reply on Twitter 1522258567692177409 Retweet on Twitter 1522258567692177409 1 Like on Twitter 1522258567692177409 4 Twitter 1522258567692177409
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2022 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login